“…These factors could be (1) loss of physiological DA clearance due to reduction of striatal DAT expression after destruction of DA terminals, (2) loss of co-transmitters or modulators, like glutamate, serotonin, GABA or cholecystokinin, that have been reported to be released from DA terminals, (3) loss of trophic factors, e.g. brain-derived neurotrophic factor, that are produced by DA neurons, or (4) processes related to inflammation and/or gliosis that follow loss of DA neurons (Altar et al, 1997; Hnasko et al, 2010; Hokfelt et al, 1980; Nagatsu and Sawada, 2006; Seroogy et al, 1988; Seutin, 2005; Tritsch et al, 2012; Wallen-Mackenzie et al, 2010; Zhou et al, 2005). …”